Hepatitis C virus enzyme sites revealed

Jul 24, 2006

U.S. researchers say the crystal structure of one of the hepatitis C viral proteins might offer new opportunities for antiviral drug design.

Charles Rice and colleagues at Rockefeller University say the viral genome encodes a single polyprotein, which cleaves into proteins including the NS2-3 protease.

The crystal structure of the protease catalytic domain reveals a novel structure: it is actually a dimer composed of two identical proteins that each contributes amino acids to two equivalent active sites.

The researchers say concentration and dimerization of NS2-3 may be a limiting factor in the viral life cycle because the protease is essential for viral replication. Therefore, details of the structure might help in the search for small-molecule inhibitors directed against the active site.

The disease affects an estimated 170 million people worldwide, often leading to cirrhosis and liver cancer.

The study is detailed in this week's issue of the journal Nature.

Copyright 2006 by United Press International

Explore further: Second western Minnesota turkey farm hit by bird flu outbreak

add to favorites email to friend print save as pdf

Related Stories

Vaccines from a reactor

Mar 02, 2015

In the event of an impending global flu pandemic, vaccine production could quickly reach its limits, as flu vaccines are still largely produced in embryonated chicken eggs. Udo Reichl, Director at the Max ...

TLR9: Two rings to bind them?

Feb 09, 2015

University of Tokyo researchers have elucidated how Toll-like receptor 9 (TLR9) binds to pathogen DNA, activating the innate immune system. This discovery is vital for the design of new antiviral, antibacterial, ...

3D reconstruction of a vital interaction

Feb 03, 2015

Researchers at IBS (CEA/CNRS/Joseph Fourier University) have succeeded for the first time in observing, on an atomic scale, the path taken and the successive changes in form undergone by a disordered vital protein, from its ...

Recommended for you

Nocturnal GERD tied to non-infectious rhinitis

4 hours ago

(HealthDay)—Nocturnal gastroesophageal reflux disease (GERD) appears to be a risk factor for non-infectious rhinitis (NIR), according to a study published online March 24 in Allergy.

Physician/Pharmacist model can improve mean BP

4 hours ago

(HealthDay)—A physician/pharmacist collaborative model can improve mean blood pressure (BP), according to a study published online March 24 in Circulation: Cardiovascular Quality and Outcomes.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.